The significance of tumor-associated neutrophil density in uterine cervical cancer treated with definitive radiotherapy

Gynecologic Oncology

Volumn 145, Issue 3, 2017, Pages 469-475

  Matsumoto, Yuri ^a   Mabuchi, Seiji ^a   Kozasa, Katsumi ^a   Kuroda, Hiromasa ^a   Sasano, Tomoyuki ^a   Yokoi, Eriko ^a   Komura, Naoko ^a   Sawada, Kenjiro ^a   Kimura, Tadashi ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cervical cancer; Radiotherapy; Survival; Tumor associated neutrophils

Indexed keywords

ANTIGEN; CD66B ANTIGEN; UNCLASSIFIED DRUG; CEACAM8 PROTEIN, HUMAN; CELL ADHESION MOLECULE; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; LEUKOCYTE ANTIGEN;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CELL DENSITY; CLINICAL FEATURE; CLINICAL OUTCOME; DISTANT METASTASIS; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HISTOLOGY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PELVIS LYMPH NODE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; TREATMENT RESPONSE; TUMOR ASSOCIATED LEUKOCYTE; TUMOR VOLUME; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; IMMUNOLOGY; MIDDLE AGED; NEUTROPHIL; PATHOLOGY; RADIATION RESPONSE; UTERINE CERVICAL NEOPLASMS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; BRACHYTHERAPY; CELL ADHESION MOLECULES; FEMALE; GPI-LINKED PROTEINS; HUMANS; MIDDLE AGED; NEOPLASM STAGING; NEUTROPHILS; RETROSPECTIVE STUDIES; UTERINE CERVICAL NEOPLASMS;

EID: 85019965898     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2017.02.009     Document Type: Article

References (28)

1. Torre, L.A., Bray, F., Siegel, R.L., Ferlay, J., Lortet-Tieulent, J., Jemal, A., Global cancer statistics, 2012. CA Cancer J. Clin. 65 (2015), 87–108.
2. Petrelli, F., De Stefani, A., Raspagliesi, F., Lorusso, D., Barni, S., Radiotherapy with concurrent cisplatin-based doublet or weekly cisplatin for cervical cancer: a systematic review and meta-analysis. Gynecol. Oncol. 134 (2014), 166–171.
3. Chemoradiotherapy for Cervical Cancer Meta-analysisCollaboration (CCCMAC). Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: individual patient data meta-analysis. Cochrane Database Syst. Rev., 2010, CD008285.
4. Chemoradiotherapy for Cervical Cancer Meta-AnalysisCollaboration. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials. J. Clin. Oncol. 26 (2008), 5802–5812.
5. Chakraborty, S., Keenportz, B., Woodward, S., Anderson, J., Colan, D., Paraneoplastic leukemoid reaction in solid tumors. Am. J. Clin. Oncol. 38 (2015), 326–330.
6. Takahashi, R., Mabuchi, S., Kawano, M., Sasano, T., Matsumoto, Y., Kuroda, H., Hisamatsu, T., Kozasa, K., Sawada, K., Hamasaki, T., Kimura, T., Prognostic significance of systemic neutrophil and leukocyte alterations in surgically treated endometrial cancer patients: a monoinstitutional study. Gynecol. Oncol. 137 (2015), 112–118.
7. Matsuo, K., Hom, M.S., Moeini, A., Machida, H., Takeshima, N., Roman, L.D., Sood, A.K., Significance of monocyte counts on tumor characteristics and survival outcome of women with endometrial cancer. Gynecol. Oncol. 138 (2015), 332–338.
8. Milne, K., Alexander, C., Webb, J.R., Sun, W., Dillon, K., Kalloger, S.E., Gilks, C.B., Clarke, B., Köbel, M., Nelson, B.H., Absolute lymphocyte count is associated with survival in ovarian cancer independent of tumor-infiltrating lymphocytes. J. Transl. Med., 10, 2012, 33.
9. Templeton, A.J., McNamara, M.G., Šeruga, B., Vera-Badillo, F.E., Aneja, P., Ocaña, A., Leibowitz-Amit, R., Sonpavde, G., Knox, J.J., Tran, B., Tannock, I.F., Amir, E., Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J. Natl. Cancer Inst., 106, 2014.
10. Templeton, A.J., Ace, O., McNamara, M.G., Al-Mubarak, M., Vera-Badillo, F.E., Hermanns, T., Seruga, B., Ocaña, A., Tannock, I.F., Amir, E., Prognostic role of platelet to lymphocyte ratio in solid tumors: a systematic review and meta-analysis. Cancer Epidemiol. Biomark. Prev. 23 (2014), 1204–1212.
11. Tavares-Murta, B.M., Mendonça, M.A., Duarte, N.L., da Silva, J.A., Mutão, T.S., Garcia, C.B., Murta, E.F., Systemic leukocyte alterations are associated with invasive uterinecervical cancer. Int. J. Gynecol. Cancer 20 (2010), 1154–1159.
12. Mabuchi, S., Matsumoto, Y., Isohashi, F., Yoshioka, Y., Ohashi, H., Morii, E., Hamasaki, T., Aozasa, K., Mutch, D.G., Kimura, T., Pretreatment leukocytosis is an indicator of poor prognosis in patients with cervical cancer. Gynecol. Oncol. 122 (2011), 25–32.
13. Mabuchi, S., Matsumoto, Y., Hamasaki, T., Kawano, M., Hisamatsu, T., Mutch, D.G., Kimura, T., Elevated white blood cell count at the time of recurrence diagnosis is an indicator of short survival in patients with recurrent cervical cancer. Int. J. Gynecol. Cancer 22 (2012), 1545–1551.
14. Mabuchi, S., Matsumoto, Y., Kawano, M., Minami, K., Seo, Y., Sasano, T., Takahashi, R., Kuroda, H., Hisamatsu, T., Kakigano, A., Hayashi, M., Sawada, K., Hamasaki, T., Morii, E., Kurachi, H., Matsuura, N., Kimura, T., Uterine cervical cancer displaying tumor-related leukocytosis: a distinct clinical entity with radioresistant feature. J. Natl. Cancer Inst., 106, 2014.
15. Onal, C., Guler, O.C., Yildirim, B.A., Prognostic use of pretreatment hematologic parameters in patients receiving definitive chemoradiotherapy for cervical cancer. Int. J. Gynecol. Cancer 26 (2016), 1169–1175.
16. Moses, K., Brandau, S., Human neutrophils: their role in cancer and relation to myeloid-derived suppressor cells. Semin. Immunol. 28 (2016), 187–196.
17. Gentles, A.J., Newman, A.M., Liu, C.L., Bratman, S.V., Feng, W., Kim, D., Nair, V.S., Xu, Y., Khuong, A., Hoang, C.D., Diehn, M., West, R.B., Plevritis, S.K., Alizadeh, A.A., The prognostic landscape of genes and infiltrating immune cells across human cancers. Nat. Med. 21 (2015), 938–945.
18. Carus, A., Ladekarl, M., Hager, H., Nedergaard, B.S., Donskov, F., Tumour-associated CD66b + neutrophil count is an independent prognostic factor for recurrence in localised cervical cancer. Br. J. Cancer 108 (2013), 2116–2122.
19. Mabuchi, S., Ugaki, H., Isohashi, F., Yoshioka, Y., Temma, K., Yada-Hashimoto, N., Takeda, T., Yamamoto, T., Yoshino, K., Nakajima, R., Kuragaki, C., Morishige, K., Enomoto, T., Inoue, T., Kimura, T., Concurrent weekly nedaplatin, external beam radiotherapy and high-dose-rate brachytherapy in patients with FIGO stage IIIb cervical cancer: a comparison with a cohort treated by radiotherapy alone. Gynecol. Obstet. Investig. 69 (2010), 224–232.
20. Mabuchi, S., Isohashi, F., Maruoka, S., Hisamatsu, T., Takiuchi, T., Yoshioka, Y., Kimura, T., Post-treatment follow-up procedures in cervical cancer patients previously treated with radiotherapy. Arch. Gynecol. Obstet. 286 (2012), 179–185.
21. NCT01755845. Clinical Trials.gov. A Service of the U.S. National Institute of Health. ( http://www.clinicaltrials.gov (Accessed December 1, 2016)).
22. NCT01414608. Clinical Trials.gov. A Service of the U.S. National Institute of Health. ( http://www.clinicaltrials.gov (Accessed December 1, 2016)).
23. De Vlaeminck, Y., González-Rascón, A., Goyvaerts, C., Breckpot, K., Cancer-associated myeloid regulatory cells. Front. Immunol., 7, 2016, 113.
24. Jamieson, T., Clarke, M., Steele, C.W., Samuel, M.S., Neumann, J., Jung, A., Huels, D., Olson, M.F., Das, S., Nibbs, R.J., Sansom, O.J., Inhibition of CXCR2 profoundly suppresses inflammation-driven and spontaneous tumorigenesis. J. Clin. Invest. 122 (2012), 3127–3144.
25. Jurcevic, S., Humfrey, C., Uddin, M., Warrington, S., Larsson, B., Keen, C., The effect of a selective CXCR2 antagonist (AZD5069) on human blood neutrophil count and innate immune functions. Br. J. Clin. Pharmacol. 80 (2015), 1324–1336.
26. Stone, S.C., Rossetti, R.A., Lima, A.M., Lepique, A.P., HPV associated tumor cells control tumor microenvironment and leukocytosis in experimental models. Immun. Inflamm. Dis. 2 (2014), 63–75.
27. Olsson, A.K., Cedervall, J., NETosis in cancer - platelet-neutrophil crosstalk promotes tumor-associated pathology. Front. Immunol., 7, 2016, 373, 10.3389/fimmu.2016.00373.
28. Kjeldsberg, C.R., Letter: platelet satellitism. N. Engl. J. Med., 290, 1974, 165, 10.1056/NEJM197401172900318.